Dysfunctional EPCs in both patients with T2DM and diabetic mice disrupts endothelial repair and increases the risk for limb amputation, whereas Nrf2 stimulation, as a potential vascular reparative intervention, can restore the cell migration and neovascularization capacity and simultaneously rescue EPC senescence for management of diabetes mellitus. This evidence concerns the gene NFE2L2 and diabetes mellitus.